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RA right atrium 
RV right ventricle 
LA left ventricle 
RVDC Right ventricular diastolic collapse 
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1 
INTRODUCTION 
Pleural effusion is a medical emergency if it is more than moderate. 
Pleural effusion of any etiology may compromise pulmonary function resulting 
in dyspnea. The close relation between pleura and pericardium and the 
dependence of their pressure kinetics are well known factors. Many literatures 
on pleural effusion deal with the effect of pleural effusion on gaseous functions 
and diaphragmatic functions
1, 2, 3, 4
and literatures are very few on the effects of 
pleural effusion on cardiovascular hemodynamics
5
. So a study on the impact of 
pleural effusion on cardiovascular hemodynamics taking into consideration all 
possible variables will bring into limelight the relationship between these two 
cavities and help to formulate concepts that may provide some insight into the 
pathophysiology of symptoms in pleural effusion. 
The mediastinal pleura and the pericardium are closely related
6
.In pleural 
effusion there is a gradient in the pleural pressure due to the hydrostatic column 
of fluid
6,7
. Accordingly, the pleural pressure in the dependent part of the 
hemithorax is much greater than that in the superior part of the hemithorax. So 
the collections in the pleural cavity can compromise cardiac function mimicking 
a tamponade. There are few case reports on cardiac chamber collapse in cases of 
massive pleural effusion
8,9
. Intra thoracic pressure is transmitted to cardiac 
chambers through pericardium, and one of the important determinants of 
intrathoracic pressure is intrapleural pressure. Intra pericardial pressure both 
approximates and varies with pleural pressure. The inspiratory decrement in 
2 
pleural pressure normally reduces pericardial pressure, RA, RV, pulmonary 
capillary wedge pressure and systemic arterial pressure slightly. 
It has been shown in a canine model that large bilateral pleural effusions 
lead to an increase in intrapleural pressure
8
, which causes a linear increase in 
intrapericardial pressure finally leading to right ventricular diastolic collapse
10, 
11
. So cardiac tamponade physiology is not only related to pericardial effusions. 
Large pleural effusions of various etiologies, in the absence of significant 
pericardial effusions, have been reported to lead to cardiac tamponade 
physiology. Clinical manifestations of large pleural effusions include 
hemodynamic instability and pulsus paradoxus. Larger effusions and bilateral 
effusions cause higher incidence of ventricular collapse and hemodynamic 
instability. 
  
3 
AIMS AND OBJECTIVES 
 To study the impact of pleural effusion on cardiovascular hemodynamics. 
 To analyse whether the sidedness of pleural effusion has any impact on 
cardiovascular hemodynamics. 
 To study the cardiovascular hemodynamics after therapeutic intervention 
of pleural effusion. 
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REVIEW OF LITERATURE 
The pleura is a thin serous layer, which covers the lungs (visceral pleura) 
and is reflected, by way of the lung hila, on to the chest wall and pericardium 
(parietal pleura).The pleural space thus created extends from the root of the 
neck, 3 cm above the mid-point of the clavicle, down behind the abdominal 
cavity, in the costo-diaphragmatic recess, to the 12th rib overlying the 
kidney
12
.Only a thin layer of pleural fluid separates the parietal and visceral 
pleura. The parietal layer secretes 2400mlof fluid daily, which is resorbed by 
the visceral layer
13
.Pathological collection of fluid in pleural cavity leads to 
pleural effusion. Pleural pressure increases with accumulation of fluid. When 
pleural fluid is present, its volume must be compensated for by an increase in 
the size of the thoracic cavity, a decrease in the size of the lung or a decrease in 
the size of the heart, or a combination of these changes
6
. 
Since the thoracic cavity, lungs, and heart are all distensible objects, the 
volume of each is dependent on the pressure inside minus the pressure outside. 
The presence of pleural fluid increases the pleural pressure. Since the distending 
pressure of the thoracic wall is the atmospheric pressure minus the pleural 
pressure, an increase in the pleural pressure will lead to an increase in the 
distending pressure of the thoracic cavity and an increase in the volume of the 
thoracic cavity. The distending pressure of the lungs is the alveolar pressure 
minus the pleural pressure. Therefore, an increase in the pleural pressure will 
lead to a decreased lung volume. Since the distending pressure of the heart is the 
5 
intracardiac pressure minus the pleural pressure, an increase in the pleural 
pressure will lead to a decrease in the size of the heart
6
. 
Figure 1 Relationship between pleura and pericardium
14 
 
 
Figure 2 showing the effect of massive pleural effusion on heart 
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Pericardial space anatomy: 
The pericardium is a fibroserous sac
15
 that encloses the heart and the root 
of the great vessels. Its function is to restrict excessive movements of the heart 
as a whole and to serve as a lubricated container in which the different parts of 
the heart can contract. 
The serous pericardium lines the fibrous pericardium and coats the heart. 
It is divided into parietal and visceral layers. The parietal layer lines the fibrous 
pericardium and is reflected around the roots of the great vessels to become 
continuous with the visceral layer of serous pericardium that closely covers the 
heart. 
The visceral layer is closely applied to the heart and is often called the 
epicardium. The slit like space between the parietal and visceral layers is 
referred to as the pericardial cavity. Normally, the cavity contains a small 
amount of fluid (about 50 mL), the pericardial fluid, which acts as a lubricant to 
facilitate movements of the heart. 
Pleural fluid physiology: 
The pleural space contains a tiny amount (≈0.3 ml/kg) of hypo-oncotic 
fluid (≈1 g/dl protein). Pleural fluid turnover is estimated to be ≈0.15 ml/kg/h. 
Pleural fluid is produced at parietal pleural level, mainly in the less dependent 
regions of the cavity. Reabsorption is accomplished by parietal pleural 
lymphatics in the most dependent part of the cavity, on the diaphragmatic 
surface and in the mediastinal regions. The flow rate in pleural lymphatics can 
7 
increase in response to an increase in pleural fluid filtration, acting as a negative 
feedback mechanism to control pleural liquid volume. Such control is very 
efficient, as a 10 fold increase in filtration rate would only result in a 15% 
increase in pleural fluid volume. When filtration exceeds maximum pleural 
lymphatic flow, pleural effusion occurs
16
. 
Relationship between pleura and pericardium: 
The parietal pleura has costal, mediastinal, and diaphragmatic parts and a 
cupola. The costal pleura is separated from the sternum, costal cartilages, ribs, 
and muscles by a loose connective tissue termed endothoracic fascia, which 
provides a natural cleavage plane for surgical separation of the pleura from the 
thoracic wall. Anteriorly, the costal pleura turns sharply onto the mediastinum, 
and the underlying portion of the pleural cavity is called the costomediastinal 
recess. Inferiorly, the costal pleura is continuous with the diaphragmatic pleura, 
and the underlying space is termed the costodiaphragmatic recess. In the adult, 
the anterior borders of the right and left pleurae probably meet at or near the 
median plane during a part of their course. The left anterior border sometimes 
diverges to leave a part of the pericardium uncovered (bare area). Posteriorly, 
the pleura crosses the twelfth rib. At the root of the lung, the mediastinal pleura 
turns laterally, enclosing the structures at the root and becoming continuous 
with the visceral pleura. This reflection projects downward as a tapering double 
fold called the pulmonary ligament. The mediastinal pleura is adherent to the 
pericardium except where the phrenic nerve descends between them
17
. This 
8 
relationship between mediastinal pleura and pericardium is responsible for 
transmission of pressure alterations in the pleural cavity to pericardium and 
chambers of heart. 
Mechanism of cardiac tamponade with a large pleural effusion: 
Figure 3 Mechanism of cardiac tamponade in massive pleural effusion 
 
The figure. 3 (i)
18
 demonstrates a normal subject where intrapericardial 
pressure (A mmHg) and intrapleural pressures (A mmHg) are the same. The se 
figure. 3(ii) demonstrates a model where a pleural effusion is present and the 
intrapleural pressure increases from A to A+B. The pericardial pressure is also 
increased to A+B because intrapleural pressure is transmitted to the pericardial 
sac. If there is a concomitant pericardial effusion in addition to pleural effusion, 
the intrapericardial pressure will increase further to A+B+C (figure. 3(iii)).  
PLF - pleural fluid and PE - pericardial effusion. 
Pathophysiology of cardiac tamponade: 
For each cardiac chamber, its transmural pressure ie. intracardiac pressure 
minus pericardial pressure, is a principal determinant of its filling(Transmural 
pressure is a true filling [distending] pressure that contributes to ventricular 
9 
preload.
19,20
).Normal pericardial pressure is lower than the right atrial mean and 
right ventricular diastolic pressure that right atrial transmural pressure (right 
atrial pressure minus pericardial pressure) is normally higher than its cavitary 
pressure. In tamponade, rising pericardial pressure progressively reduces the 
transmural atrial and ventricular pressure and ultimately can make the average 
transmural pressure of first the right and subsequently the left cardiac chambers 
phasically negative.
21,22
 Survival necessitates the ensuing parallel rise in 
diastolic pressures, first in the right side of the heart and later the left side of the 
heart. 
In order to adequately fill the ventricles, against the increasing pericardial 
pressure both systemic and pulmonary vascular beds must generate sufficient 
pressure. In addition cardiac chamber compliance is also reduced by pericardial 
compression, leading to progressive resistance to filling. So to increase the 
filling pressure, body starts to conserve fluid, which is a gradual adaptation, 
hence requires time, which is not possible in acute cardiac tamponade. 
As a result in case of gradually developing tamponade, diastolic pressure 
in both ventricles and pulmonary artery equilibrates with mean right and left 
atrial pressure at approximately the intra-pericardial pressure. This is the phase 
at which most patients will have frank exaggeration of respiratory fluctuation in 
arterial blood pressure (pulsus paradoxus). 
Tamponading pericardial fluid compresses the heart throughout systole 
and diastole. Although the atria fill continuously, blood mainly enters the heart 
10 
when blood is leaving it during the right and left ventricular ejection periods, 
since ventricular ejection expels blood, reducing ventricular volumes. Ejection 
thus transiently reduces pericardial pressure, transiently increasing transmural 
pressure. Ejection simultaneously aids atrial filling through enlarging the atria 
by pulling their ―floors‖ (valve levels) toward the ventricular apices22. 
Like most tamponade induced abnormalities of pressure and flow, 
transmural pressures are reciprocally reduced and increased during the 
respiratory phases for the left vs the right heart. Thus, inspiration increases right 
heart filling at the expense of the left heart with reversal in expiration. In critical 
tamponade, when cardiac output usually has fallen by at least 30%
21,23.24,25
, 
transmural pressures are, on average, zero (typically between 15 and 30 mmHg 
within the pericardium and between 15 and 30 mmHg within the heart in 
euvolemic patients) so that respiratory reciprocation becomes a principal 
physiologic mechanism contributing at some level to cardiac input and output. 
A significant component of respiratory reciprocation is the marked shift of the 
ventricular septum into the left ventricle when inspiration fills the right heart at 
the expense of the left with reversal on expiration. Clinically, respiratory 
reciprocation is expressed as pulsus paradoxus. 
Echo parameters used to confirm cardiac tamponade: 
The criteria
26,27
 that suggest cardiac tamponade by echocardiogram are: 
1. Right ventricular diastolic and right atrial collapse9,28,9,30,31. 
11 
2. Interventricular septum deviation toward the left ventricular cavity on 
inspiration. 
3. An increase in trans-mitral inflow E wave velocity of more than 25% on 
expiration and/or increase in tricuspid inflow E wave velocity by greater 
than 40% on inspiration. 
4. Inspiratory variation of peak aortic and pulmonary flow velocities32. 
5. Inferior vena cava diameter and its variation with respiration. 
The normal trans-AV valvular flow profile has two peaks - an E and an A 
wave. The E peak arises due to early diastolic filling. Most filling (70-75%) of 
the ventricle occurs during this phase. The A peak arises due to atrial 
contraction, forcing approximately 20-25% of stroke volume into the ventricle. 
Classically, the E-wave velocity is slightly greater than that of the A wave. As 
the normal output of ventricles varies with respiration, so varies the peak of 
Eand A velocity during phases of respiration. This phenomenon is exaggerated 
in cardiac tamponade and is taken as a marker for tamponade. 
Previous studies: 
Few animal studies were done to establish the hypothesis that massive 
pleural effusion can cause cardiac tamponade like physiology, based on the 
concept of close approximation of both pleura around the heart and the close 
relationship between intra-pleural and intra-pericardial pressure during normal 
quite respiration. 
12 
Vaska
8
 et al demonstrated that right ventricular diastolic collapse
28
 was 
produced by intrapleural instillation of fluid in a canine model. It was observed 
that the larger the pleural effusion, the higher the pericardial pressure. In the 
study by Vaska et al, the following figures give relationship between various 
parameters and intra-pericardial pressure, with instillation of fluid in pericardial 
space and pleural space. 
Figure 4Relationship between pleural and pericardial pressure during intrapleural 
instillation (dotted lines) and intrapericardial instillation (solid lines) of fluid 
 
 
Figure 4 shows that, with intra-pleural instillation of fluid, the relationship 
between pleural pressure and intra-pericardial pressure rise is linear, whereas 
with intra-pericardial instillation of fluid, intra-pericardial pressure rises 
promptly but with minimal increase in pleural pressure. 
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Figure 5 Showing relationship between intra-pericardial pressure and cardiac output 
with intra-pleural (dotted lines) and intra-pericardial instillation of fluid (solid lines) 
 
From Figure 5, it is clear that intra-pericardial pressure rises with both 
intra-pleural and intra-pericardial instillation of fluid, but more steeply with 
intrapericardial instillation of fluid, compared to intra-pleural instillation. When 
cardiac output is compared, intra-pleural fluid instillation is better tolerated than 
intra-pericardial instillation of fluid, due to less abrupt fall in cardiac output in 
the former. 
Wrisleyetal
28
 had demonstrated marked diastolic collapse of right atrium 
without hemodynamic compromise in dogs. Similar results were obtained from 
animal studies conducted by Kaplan et al
29
 and Venkatesh et al
33
. 
Echocardiographic evidence of cardiac tamponade in patients with pleural 
effusion without pericardial effusion was shown by Arasadaniantz et al
9
, who 
14 
reported that in 116 patients with pleural effusion with no pericardial effusion 
18% had evidence of cardiac chamber collapse on echocardiography. 
Traylor et al
34
 evaluated 37 patients with large pleural effusion with 
echocardiographic and clinical signs of cardiac tamponade
9
. In their study, the 
patients were divided into two groups. Group 1: Pleural effusions occupying 
less than a hemithorax, (n = 10). Group 2: Effusions greater than a hemithorax 
on chest X ray, (n = 27). Group 1 patients had no clinical or echocardiographic 
signs of cardiac tamponade. However, in Group 2, 8 subjects had elevated JVP, 
8 had pulsus paradoxus, 6 had RV diastolic collapse, and 23 had flow velocity 
paradoxus. Those signs of cardiac tamponade resolved completely in 20 patients 
after thoracentesis. Pericardiocentesis was not performed in any of these 
patients. In terms of sidedness of pleural effusion, group 2 showed that 11 
patients had left, 8 had right, and 8 had bilateral pleural effusions. Although the 
study clearly demonstrated size of pleural effusion is an important factor, 
location of pleural fluid did not have a significant impact on cardiac tamponade 
physiology. 
In the study by Traylor et al. in group 2, 8 patients had small pericardial 
effusion (not quantitated). Studies had shown that size of pericardial effusion is 
not linearly related to intra-pericardial pressure and any acute increase in 
quantity of pericardial fluid can result in cardiac tamponade, rather than 
absolute quantity of fluid increase. So as there are no clues to rapidity of fluid 
accumulation in study by Traylor et al. there exists possibility of pericardial 
15 
effusion being a confounder. So this study was planned to exclude all 
pericardial effusions, however trivial they may be. 
Other assumptions and procedures were planned similar Traylor et.al
34
. 
Right ventricular diastolic collapse is a sensitive and specific indicator for 
the early detection of hemodynamically important pericardial effusions and is 
used in experimental studies on pleural effusion. Traylor et al had noted right 
atrial collapse, which is the commonly used marker for tamponade physiology, 
as RVDC occurs early in the course of tamponade than right atrial collapse. 
In addition to flow velocity paradoxus across AV valves all possible 
parameters involved in cardiac tamponade like pulmonary artery and aortic 
respiratory variations RA,RV,LA sizes before and after thoracentesis were 
included in this study. 
Further improvement, in defining the concept can be done by future 
studies with invasive monitoring of pleural pressure, pericardial pressure and 
cardiac chambers before and after thoracentesis and correlating them. 
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MATERIALS AND METHODS 
Setting : In-patient department, 
   Institute of Internal Medicine, 
   Rajiv Gandhi Government General Hospital, 
   Madras Medical College, Chennai. 
  Echocardiography lab, 
   Department of cardiology, 
   Madras Medical College, Chennai. 
 
Sampling technique : Convenient sampling 
Ethical committee approval : Obtained 
Design of the study : Prospective study 
Period of study : April 2011 to November 2011 
Sample size : 40 patients 
  
17 
Inclusion Criteria: 
1. Age > 12 
2. Unilateral or bilateral massive pleural effusion of non-cardiac etiology 
Exclusion Criteria: 
1. Pleural effusion secondary to cardiac disease 
2. Constrictive pericarditis 
3. Pericardial effusion 
Case Definition: 
In our study, the criteria used for classifying massive pleural effusion is 
any pleural effusion with chest x-ray postero-anterior view showing 
homogenous opacity greater than or equal to ¾ of one or both hemithorax. 
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METHODOLOGY AND INVESTIGATION DETAILS OF PATIENTS 
After obtaining informed and written consent, patients above the age of 
12 years who had unilateral or bilateral massive pleural effusion of non-cardiac 
etiology were included in the study. Patients with pleural effusion secondary to 
cardiac disease and patients with constrictive pericarditis, patients with mild and 
moderate pleural effusion (less than ¾ of a hemithorax) were excluded from the 
study. Patients were selected from inpatients wards in Institute of internal 
medicine, where they were evaluated for pleural effusion. 
Relevant history, physical examination, chest X ray, electrocardiogram 
were done for all the patients. Patients with JVP above 3 cm from sternal angle 
are noted.Spo2, pulse rate, respiratory rate, systolic and diastolic blood pressure 
were taken and patients with pulsus paradoxus are noted. All the patients 
underwent detailed echocardiographic study. The following echocardiographic 
parameters were done which includesflow velocity across tricuspid valve, mitral 
valve, pulmonary valve, and aorta, size of all the chambers and pulmonary 
artery pressures were measured. 
All the patients underwent therapeutic thorocentesis for massive pleural 
effusion.A repeat chest x ray was taken to assure that the pleural effusion 
remained less than a ½ of a hemithorax and all the clinical and echo parameters 
were measured again within 24 hours. Pre and post therapeutic echo parameters 
were compared. 
19 
Data Analysis Methods: 
Statistical analysis was done withGraphpadinstat3. Values obtained 
before and after intervention were analysed using paired t-test and significance 
of sidedness of pleural effusion, for development of cardiac tamponade 
physiology was analysed using Fisher’s exact test. 
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RESULTS 
Patients‟ demographics and clinical factors: 
Forty patients who had massive unilateral or bilateral pleural effusion 
were included in our study. Out of 40 patients, 32were male and 8 were female 
patients. 30patients had right sided, 7 had left sided and 3 had bilateral pleural 
effusion. 25 patients had pleural effusion secondary to tuberculosis and 14 
secondary to malignancy 1 due to decompensated liver disease with moderate 
ascites. Mean age of the patients was 46.6. 
 
Figure 6 Age distribution 
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Figure 7 Sex distribution 
 
 
 
 
 
 
Figure 8 Sidedness of pleural effusion 
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Figure 9 Etiologies of pleural effusion 
 
 
Figure 10 X-ray of a patient with right sided massive pleural effusion 
 
Out of 7 patients with left sided massive pleural effusion, 4 had elevated 
JVP and all the 4 patients also demonstrated pulsus paradoxus. In case of right 
sided pleural effusion, out of 30 cases with massive pleural effusion 13had 
62.5% 
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DECOMPENSATED
CHR0NIC LIVER
DISEASE
23 
elevated JVP and 18demonstrated pulsus paradoxus, whereas all three patients 
who had bilateral pleural effusion with at least one hemithorax meeting the 
inclusion criteria had both elevated JVP and pulsus paradoxus. 
Figure 11 Elevated JVP in the study group 
 
 
 
Figure 12 Pulsus paradoxus in the study group 
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Figure 13 Relative percentage of patients in each group with pulsus paradoxus and 
elevated JVP 
 
As shown in table 1, before thorocentesis, SpO2 (mean ± SD) 
was97%±1.3%, pulse rate was101.75±4.8, systolic blood pressure 
was110.2±9.2, and diastolic blood pressure was 75±7.3. After thorocentesis, 
SpO2was 98%±0.9, pulse rate was 93.43±3.5, systolic blood pressure 
was114.40±7.6, and diastolic blood pressure was 78.60±4.6. 
Table 1 
Parameter Before Thoracentesis After Thoracentesis 
SPO2 97%±1.3% 98%±0.9% 
Systolic BP 110.2±9.2 114.40±7.6 
Diastolic BP 75±7.3 78.60±4.6 
Pulse rate 101.75±4.8 93.43±3.5 
43% 
46% 
100% 
43% 
63% 
100% 
7 
30 
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Figure 14 Mean SpO2, systolic BP, diastolic BP, pulse rate before and after 
thoracentesis 
 
 
 
 
Figure 15 SpO2 values before and after thoracentesis 
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Figure 16 Pulse rate in study patients before and after thoracentesis 
 
 
 
 
 
Figure 17 Systolic blood pressure in study patients before and after thoracentesis 
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Figure 18 Diastolic blood pressure in study patients before and after thoracentesis 
 
 
Echocardiographic parameters: 
Chamber size before thoracentesis, mean right atrial size 3.40cm, mean 
left atrial size 3.5cm, mean left ventricular systolic diameter 3.12 cm, mean left 
ventricular diastolic diameter 5.1cm. Mean right ventricular measurements at 
the basal, mid and base to apex were 2.4 cm, 2.93 cm, and 7.37 cm respectively. 
After thoracentesis, mean right atrial size 3.32 cm , mean left atrial size 3.42 
cm, mean left ventricular systolic diameter 3.26cm, mean diastolic diameter 5.2 
cm, mean right ventricular measurements at the basal, mid and base to apex 
measurements 2.45 cm, 2.98 cm,7.45 cm respectively and 6 patients had right 
atrial collapse. 
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Figure 19 Echo showing right atrial collapse
35
 
 
 
 
Figure 20 right atrial size before and after thoracentesis 
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Figure 21 left atrial size before and after thoracentesis 
 
 
 
 
 
Figure 22 left ventricular dimension before and after thoracentesis 
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Figure 23 left ventricular diastolic size before and after thoracentesis 
 
 
 
 
 
Figure 24 right ventricular size at base before and after thoracentesis 
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Figure 25 right ventricular size at mid-level before and after thoracentesis 
 
 
 
 
 
Figure 26 right ventricular size (base to apex) before and after thoracentesis 
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Table 2 showing mean chamber size before and after thoracentesis 
 
Parameter 
Before Thoracentesis 
(cm) 
After Thoracentesis 
(cm) 
mean RA size 3.40 3.32 
mean RV size – basal 2.4 2.45 
mean RV size  - mid 2.93 2.98 
mean RV size – base to 
apex 
7.37 7.45 
mean LA size 3.5 3.42 
 mean LV systolic 
diameter 
3.12 3.26 
LV diastolic diameter 5.1 5.2 
 
Before thoracentesis mean flow velocity across tricuspid valve during 
inspiration (E) - 74.47cm/s,(A) - 63.77cm/s; during expiration (E) - 52 cm/s, (A) 
- 42.825 cm/s. Mean flow velocity across mitral valve during expiration (E) -
70.7 cm/s, (A) - 72.4 cm/s; during inspiration (E) - 53.6 cm/s , (A) - 57.8 cm/s. 
Mean flow velocity across pulmonary artery during inspiration was 85.65 cm/s, 
and during expiration was 63.27cm/s. Mean flow velocity across aorta during 
expiration was 86.2 cm/s and during inspiration was 71.68 cm/s. 
After thoracentesis, mean flow velocity across tricuspid valve during 
inspiration (E) - 68.4 cm/s, (A) - 62 cm/s; during expiration (E) - 52.2 cm/s, (A) 
- 47.5 cm/s. Mean flow velocity across mitral valve during expiration (E) - 65.3 
33 
cm/s, (A) - 70.3 cm/s; during inspiration (E) - 54.55 cm/s, (A) - 58.32 cm/s. 
Mean flow velocity across pulmonary artery during inspiration was 81.46 cm/s, 
and during expiration was 70 cm/s. Mean flow velocity across aorta during 
expiration was 79.5cm/s and during inspiration was 70 cm/s. 
 
 
 
Figure 27 measurement of mitral E, A velocities 
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Figure 28 measurement of tricuspid E, A velocities 
 
 
Figure 29 measurement of aortic flow velocities 
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Figure 30 measurement of pulmonary artery flow velocities 
 
 
 
Figure 31 measurement of LV function 
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Figure 32 mitral E velocity variation before and after thoracentesis 
 
 
 
 
 
Figure 33 mitral A velocity variation before and after thoracentesis 
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Figure 34 tricuspid E velocity variation before and after thoracentesis 
 
 
 
 
 
Figure 35 tricuspid A velocity variation before and after thoracentesis 
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Figure 36 pulmorary artery flow velocity variation before and after thoracentesis 
 
 
 
 
 
 
Figure 37 aortic flow velocity variation before and after thoracentesis 
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Figure 38 mean respiratory variation across AV valves, pulmonary and aortic valve 
 
 
 
Table 3 showing mean flow velocities across A-V valves and semilunar valves 
before and after thoracentesis 
Table 3 
Parameter 
(Mean Respiratory 
Variation) 
BeforeThoracentesis 
Normal 
Values 
After 
Thoracentesis 
Tricuspid E  45.04±10.4% <40% 32±11.3% 
Tricuspid A 53.71±28% <40% 32.08±12.5% 
Mitral E  32.30±12 %, <25% 19.78±7.8% 
Mitral A 26±11.2% <25% 21±9.3% 
Pulmonary artery 42.63±31.3% <10% 17.70±6.2% 
Aorta  21.57±11.4% <15% 14.08±7.6% 
 
  
0
10
20
30
40
50
60
mean respiratory variation before
thoracentesis in cm/sec
mean respiratory variation after
thoracentesis in cm/sec
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Mean flow velocity respiratory variations, across tricuspid valve before 
thoracentesis and after thoracentesis were E- 45.04±10.3, E - 32±11.3% (p value 
< 0.001); A - 53.71±29%, A- 32.08±12.5% (p < 0.001); across mitral valve E - 
32.30±12.7 %, E - 19.78±7.8% (p < 0.001); A - 26±11.2 %, A- 21±9.3% (p < 
0.001); across pulmonary artery 42.63±31.3%, and 17.70±6.2% (p < 0.001); 
across aorta 21.57±11.4% , 14.08±7.6 % (p < 0.001). The cut off values to 
designate the respiratory variations in flow velocities as remarkable and 
representative of cardiac tamponade, for mitral, tricuspid, pulmonary and aorta 
were >25%, >40%, >10%, >15% respectively. 
Table 4 
  Mean N 
Standard 
Deviation 
Pair 1 
Mitral E BTC 0.3230 40 0.127 
Mitral E ATC 0.1978 40 0.077 
Pair 2 
Mitral A BTC 0.2597 40 0.1122 
Mitral A ATC 0.2099 40 0.093 
Pair 3 
Tricuspid E BTC 0.4504 40 0.1035 
Tricuspid E ATC 0.3199 40 0.1135 
Pair 4 
Tricuspid A BTC 0.5371 40 0.29 
Tricuspid A ATC 0.3209 40 0.13 
Pair 5 
Pulmonary BTC 0.4263 40 0.31 
Pulmonary ATC 0.1771 40 0.062 
Pair 6 
Aorta BTC 0.2157 40 0.11 
Aorta ATC 0.141 40 0.075 
 
BTC- before thoracentesis 
ATC - after thoracentesis 
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Table 5 
  N 
Std. Error 
Mean 
Two tailed „P‟ 
value 
Pair 1 
Mitral E BTC 40 0.02 
0.000 
Mitral E ATC 40 0.01 
Pair 2 
Mitral A BTC 40 0.018 
0.006 
Mitral A ATC 40 0.014 
Pair 3 
Tricuspid E BTC 40 0.016 
0.000 
Tricuspid E ATC 40 0.018 
Pair 4 
Tricuspid A BTC 40 0.046 
0.000 
Tricuspid A ATC 40 0.02 
Pair 5 
Pulmonary BTC 40 0.050 
0.000 
Pulmonary ATC 40 0.01 
Pair 6 
Aorta BTC 40 0.02 
0.000 
Aorta ATC 40 0.012 
 
From table 4, it is clear that the average respiratory variation across AV 
valves, pulmonary valve, and aortic valve, before thoracentesis showed values 
found in cardiac tamponade and after thoracentesis the values reduced to normal 
range, which was statistically significant, implying that massive pleural effusion 
can cause cardiac tamponade physiology 
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Table 6 
  Mean N 
Std. 
Deviation 
Std. 
Error 
Mean 
Two 
tailed 
„P‟ 
value 
Pair 1 
SPO2 BTC 97.2609 40 1.3 0.25318 0.348 
SPO2 ATC 98.2609 40 0.9 0.16890 
Pair 2 
PR BTC 101 40 4.8 0.75 0.000 
PR ATC 93 40 3.52 0.56 
Pair 3 
SYS BP BTC 110 40 9.2 1.45 0.001 
SYS BP ATC 114.4 40 7.64 1.20 
Pair 4 
DIA BP BTC 75 40 7.3 1.15 0.000 
DIA BP ATC 78.6 40 4.56 0.72 
 
BTC – before thoracentesis 
ATC- After thoracentesis 
 
From the table 5, it is clear that for Spo2, pulse rate, systolic and diastolic 
blood pressure before and after thoracentesis, on correlation by statistical 
analysis got p values as 0.348, 0.0001, 0.001, and 0.0001 respectively.  
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Regarding chamber size changes before and after thoracentesis, the right 
atrium, left atrium, left ventricle systolic and diastolic, right ventricle basal, 
mid, base to apex, p values are 0.001, 0.0001,0.9, 0.0001,0.0056,0.0021,0.0003 
respectively, which is depicted in tables 6 and 7. 
Using Fisher’s exact test for statistical significance, there is no 
significance for sidedness of pleural effusion on cardiac tamponade physiology 
in our study and the sample population is also small, to represent a true 
validation. 
Table 7 
  Mean N 
Std. 
Deviation 
Std. Error 
Mean 
Pair 1 
RA cm BTC 3.41 40 0.2179 0.034 
RA cm ATC 3.33 40 0.1728 0.027 
Pair 2 
LA cm BTC 3.50 40 0.23 0.04 
LA cm ATC 3.42 40 0.21 0.03 
Pair 3 
LV sys BTC 3.1 40 0.245 0.04 
LY sys ATC 3.26 40 0.315 0.05 
Pair 4 
LV dias BTC 5.11 40 0.21 0.03 
LV dias ATC 5.19 40 0.16 0.02 
Pair 5 
RV  basal BTC 2.4 40 0.24 0.04 
RV basal ATC 2.45 40 0.20 0.03 
Pair 6 
RV mid BTC 2.93 40 0.21 0.033 
RV mid ATC 2.98 40 0.205 0.032 
Pair 7 
RV base-apex BTC 7.375 40 0.213 0.033 
RV base-apex ATC 7.445 40 0.196 0.031 
 
  
44 
 
Table 8 
 
  N Sig. 
Pair 1 RA cm BTC & RA cm ATC 40 0.000 
Pair 2 LA cm BTC & LA cm ATC 40 0.001 
Pair 3 LV sys  BTC& LV sys ATC 40 0.0018 
Pair 4 LV dias BTC & LV dias ATC 40 0.000 
Pair 5 RV  basal BTC & RV basal ATC 40 0.006 
Pair 6 RV mid  BTC& RV mid ATC 40 0.002 
Pair 7 RV base-apex BTC & RV base-apex ATC 40 0.003 
 
  
45 
DISCUSSION 
 This study was undertaken to establish the concept of cardiovascular 
hemodynamics alteration in massive pleural effusion, which could also be a 
reason for breathlessness, in addition to ventilation perfusion mismatch. 
 Previous animal experiments and patient studies had proved the cardiac 
tamponade physiology in massive pleural effusion, but with only a few 
parameters analysed and with confounders like small pericardial effusion, as in 
study by Traylor et al, it appears, therefore justified to make an attempt to rule 
out all possible confounders and to invoke all possible parameters altered in 
cardiac tamponade, to bring this concept to limelight. 
In the study, out of 40 patients who had pleural effusion greater than ¾ of 
a hemithorax, 32 were males and 8 were females. Bilateral pleural effusion was 
found in 3 patients and of the remaining, 7 had left sided pleural effusion and 30 
had right sided pleural effusion. Regarding etiology, in 25 cases it was due to 
tuberculosis, in the remaining, 1 case had decompensated liver disease and rest 
14 had lung malignancy. Traylor et al
34
had studied a total of 27 patients 
dividing them into 2 groups, one with pleural effusion greater than ½ of 
hemithorax and the other with pleural effusion less than half of a hemithoarax.  
In our study, 50% of patients had elevated jugular venous pressure and 
63% had clinical evidence of pulsus paradoxus, 100% of bilateral effusions 
showed both, in comparison with Traylor et.al who had shown 36% in a group 
with pleural effusion greater than 1 hemithorax. 
46 
In echo parameters, for cardiac tamponade, 15% of the patients had right 
atrial collapse (which included 3 patients with bilateral pleural effusion, 2 
patients with right sided pleural effusion, and 1 patient with left sided pleural 
effusion). 85% of the patients had significant tricuspid flow velocity respiratory 
variations, 80% had significant mitral flow velocity respiratory variations, 100% 
had significant pulmonary artery respiratory flow variation, and 85% had 
significant aortic flow velocity respiratory variation, all of which came to 
normal values after thoracentesis with significant p value. 
 The amount of pleural fluid tapped ranged from 1750ml to 2500ml, after 
which a repeat chest x ray was taken to assure that the pleural effusion remained 
less than a ½ of a hemithorax and all the clinical and echo parameters measured 
again within 24 hours. No chest tubes were placed for patients during study 
period. In Traylor et al. the amount of pleural fluid ranged from  2,000 to 4,000 
ml (mean 3,050).  
In Traylor et al. both groups, one with pleural effusion greater than 1 
hemithorax, and the other with effusion less than a hemithorax, some patients, 
in addition, had small pericardial effusion, which could act as a confounder. 
This cofounder was eliminated in this study right from beginning by excluding 
patients with, even mild pericardial effusion from the study. 
In this study, we had included other parameters, which could possibly be 
affected by the pressure changes in the pleural cavity, pericardial cavity like  
RA size,  
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RV size at basal, mid septal level, and from base to apex, 
LA size, 
LV systolic dimension and  
LV diastolic dimension. 
From tables 7 and 8 it is clear that the parameters of cardiac chamber size of 
both right and left side of the heart, had shown statistically significant alteration 
with massive pleural effusion, before and after thoracentesis, reflecting that 
pressure changes in pleural cavity due to massive pleural effusion are 
transmitted to cardiac chambers through pericardium space, generating 
respiratory flow velocity variations 
On comparing, clinical parameters reflecting hemodynamic status like 
SpO2, pulse rate, systolic blood pressure and diastolic blood pressure, before and 
after thoracentesis of massive pleural effusion in the study there is a statistically 
significant alteration in pulse rate, systolic blood pressure and diastolic blood 
pressure. 
Regarding sidedness of pleural effusion, and clinically detected evidence of 
cardiac tamponade like elevated jugular venous pulse and pulsus paradoxus, in 
our study, no statistically significant correlation was found and any conclusion 
regarding sidedness of pleural effusion causing cardiac tamponade requires an 
invasive study, measuring and correlating intra-pleural, intra-pericardial 
pressure and cardiac chamber pressure to find out a plausible mechanism, to be 
carried out  in a large population sample. 
48 
Even those patients who had massive pleural effusion without showing 
tricuspid and mitral respiratory variation not amounting to cardiac tamponade 
had their values well above the normal. This could be explained by the fact that 
there are significant interindividual variation in the size of heart, lungs, pleural 
cavities with their surrounding pleura,  which determines the closeness contact 
of the pleura and pericardium , which in turn determines  the  amount of area of 
compression on the heart when the pleura is distended with pathological fluid 
collection. Moreover unlike pneumothorax which uniformly increases pleural 
pressure, pleural effusion creates a gradation in pleural pressure
6, 7
, due to the 
dependency based distribution of fluid as well as the consistency of 
accumulating fluid.  
This concept can be made clearer still, by further studies with invasive 
measurements correlating intra-pleural pressure, intra-pericardial pressure and 
cardiac chamber and great arteries pressure. 
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LIMITATIONS OF THE STUDY 
1. Patients, who had significant respiratory flow variations across valves, 
yet, not amounting to tamponade features clinically, could not be 
explained clearly without invasive monitoring of pleural, pericardial and 
cardiac chamber pressures. 
2. The exact location and distribution of pleural effusion cannot be 
ascertained only from chest x ray film, and needs a CT chest, which could 
explain why some patients with relatively lesser quantity of pleural 
effusion demonstrate remarkable tamponade physiology, whereas, some 
with larger quantities does not, was not planned in this study.  
3. Because of the small study group, effect of sidedness of pleural effusion 
on cardiovascular hemodynamic alteration, could not be commented with 
statistical significance. 
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CONCLUSION 
1. This study establishes that massive pleural effusion can have significant 
hemodynamic impairment as evidenced by altered Doppler AV filling 
profile. 
2. Regarding sidedness of pleural effusion, there is no significant correlation 
between side of massive pleural effusion and development of cardiac 
tamponade physiology in this study. 
3. There was no elevation of pulmonary arterial pressure in spite of 
mechanical effect of pleural effusion over the lung vasculature. 
4. We believe that one of the mechanisms of dyspnoea in massive pleural 
effusion could be related to the compromise in cardiac hemodynamics. 
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PROFORMA 
Age   
Male   
Female   
Clinical parameters  
Systolic blood pressure   
Diastolic blood pressure   
Elevated JVP  
Pulsus paradoxus  
Pulse rate   
Respiratory rate   
Spo2  
Co-morbid conditions   
Diabetes   
Systemic hypertension   
Renal failure  
Tuberculosis   
Malignancies   
HIV  
Heart failure   
Constrictive pericarditis  
Pericardial effusion  
  
57 
ECHO PARAMETERS 
Parameter 
Before 
Thoracentesis 
After 
Thoracentesis 
Mitral A inspiration   
Mitral A expiration   
Mitral E inspiration   
Mitral E expiration    
Tricuspid A inspiration   
Tricuspid A expiration   
Tricuspid E inspiration   
Tricuspid E expiration   
Pulmonary flow velocity inspiration    
Pulmonary flow velocity expiration    
Aortic flow velocity Inspiration   
Aortic flow velocity expiration   
RA size   
LA size   
RV  size base    
RV size at mid-septal level   
RV size base to apex   
LV systolic dimension   
LV diastolic dimension   
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MASTER CHART 
BEFORE THORACENTESIS 
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4 47 M MALIG R N N 3.1 3.3 3 5.1 2.2 2.7 7.4 56 70 54 67 82 56 70 49 98 82 56 70 95% 98 100 70 
5 32 F TB R Y Y 3.8 3.7 2.7 4.8 2.6 2.9 7.2 60 80 46 60 81 56 58 42 81 64 75 63 97% 102 110 70 
6 47 M TB R N N 3.4 3.6 3.1 5 2 2.7 7.1 59 72 54 69 65 46 47 35 79 63 60 76 99% 100 100 78 
7 39 M TB R Y Y 3.1 3.5 3.3 5.3 2.3 3.1 7.6 44 59 60 73 69 49 62 46 90 72 80 68 98% 97 110 80 
8 57 M TB R N N 3.5 3.6 3.2 5.1 2.6 3.1 7.4 54 69 51 64 72 51 46 32 106 90 52 66 99% 103 120 78 
9 59 M MALIG R N Y 3.5 3.7 3.5 5.4 2.7 3 7.3 56 72 63 81 80 60 78 69 80 59 67 83 97% 100 114 80 
10 65 M TB L Y Y 3.2 3.1 3 5.1 2.8 3.1 7.3 57 70 58 72 76 58 74 55 74 65 74 90 98% 96 112 80 
11 45 M MALIG R N N 3.6 3.6 2.9 4.9 2.2 2.9 7.8 58 72 65 85 69 48 72 52 75 60 70 87 97% 98 110 70 
12 37 M MALIG R N N 3.7 3.9 3.1 5 2.1 2.7 7.1 54 69 67 81 73 51 68 48 72 59 64 78 98% 104 110 80 
13 56 M TB R Y Y 3.6 3.7 3.4 5.4 2.1 2.8 7.6 52 68 63 79 68 47 55 39 68 56 74 90 97% 101 114 82 
14 67 M TB R Y Y 3.8 3.7 3 5.1 2.4 3 7.5 50 63 60 73 68 50 61 45 92 76 81 97 99% 104 118 78 
15 47 M TB R N N 3.4 3.3 2.8 4.9 2.3 3.1 7.4 60 73 66 78 82 64 52 40 100 85 84 98 96% 98 120 80 
16 49 M TB L Y Y 3.6 3.9 3.2 5.1 2.6 3.3 7.4 56 75 66 81 78 55 70 48 90 75 75 89 95% 105 90 64 
17 43 M TB R N Y 3.1 3.2 3.1 5 2.3 3.3 7.3 60 73 63 76 72 55 65 50 85 71 78 96 98% 109 108 70 
18 54 F TB R Y Y 3.5 3.7 3 4.9 2.1 3 7.1 50 65 59 76 79 56 72 53 76 63 74 92 97% 103 120 78 
59 
19 56 F MALIG R Y Y 3.5 3.2 2.7 5 2.2 2.9 7.3 69 91 64 85 78 54 56 40 90 72 36 45 99% 102 128 86 
20 50 M TB L Y Y 3.4 3.7 2.9 4.9 2.6 2.9 7.8 61 79 57 73 68 47 70 48 98 83 96 109 98% 99 104 78 
21 45 M TB R N N 3.1 3.3 3 5.5 2.8 2.7 7.1 52 44 50 41 63 49 60 47 94 86 90 97 97% 98 108 76 
22 46 F TB R N Y 3.7 3.1 3.1 4.9 2.1 3 7.5 46 60 40 54 51 35 47 33 81 68 58 72 96% 100 110 76 
23 40 M TB L N N 3.2 3.9 3 5.1 2.3 2.8 7.2 57 71 55 68 83 57 71 50 100 83 57 72 98% 101 110 70 
24 38 M TB R N Y 3.4 3.6 2.7 5 2.7 3 7.7 59 70 44 65 73 50 78 55 95 63 83 97 95% 102 100 60 
25 30 M MALIG B Y Y 3.6 3.2 3.4 5.2 2.6 3.2 7.6 86 110 51 68 76 51 55 35 92 89 75 91 97% 114 120 78 
26 42 F TB R N N 3.3 3.5 3.1 4.8 2.1 2.7 7.4 47 71 74 89 80 57 62 30 75 42 65 85 96% 98 116 68 
27 26 M TB L Y Y 3.5 3.4 2.9 5.3 2.4 2.4 7.4 33 43 59 77 78 54 56 35 79 43 77 91 97% 96 110 80 
28 43 M TB R Y Y 3.7 3.5 3.3 5.4 2.3 3.1 7.3 45 60 49 69 68 48 72 52 68 35 69 87 98% 100 118 78 
29 38 F MALIG R N N 3.4 3.3 2.9 5.1 2.8 2.9 7.1 47 73 66 74 72 50 62 33 64 32 87 101 96% 102 100 72 
30 60 M MALIG B Y Y 3.2 3.7 3.5 5 2.3 2.7 7.1 54 74 63 70 79 53 46 20 69 35 70 91 95% 101 96 68 
31 45 M MALIG R N N 3.5 3.5 3.6 4.8 2.5 2.5 7.6 52 73 51 66 65 40 81 40 75 40 59 75 95% 99 102 74 
32 75 M MALIG R N N 3.6 3.7 3.2 5.2 2.7 3.1 7.2 61 97 59 77 82 57 79 37 72 35 45 67 95% 105 104 86 
33 56 M TB R N N 3.1 3.5 3.4 5.2 2.1 3.2 7.7 50 74 67 80 76 40 70 51 77 37 85 99 99% 108 110 82 
34 38 M TB R Y Y 3.4 3.2 3 5.4 2.5 2.7 7.1 35 45 36 56 83 56 58 35 101 60 63 84 96% 99 124 74 
35 40 M TB R Y Y 3.3 3.3 2.6 5.1 2.3 2.9 7.5 49 73 58 80 82 53 46 20 95 58 49 70 97% 98 126 66 
36 37 M TB L Y Y 3.7 3.4 2.9 5.5 2.6 3 7.4 46 65 60 72 65 40 65 31 92 55 67 85 95% 102 116 60 
37 42 M TB R Y Y 3.2 3.6 3.2 4.8 2.1 2.8 7.3 33 46 57 78 79 53 53 34 85 50 78 97 98% 97 118 78 
38 50 M TB R N N 3.2 3.7 3.3 5 2.2 3.3 7.4 51 74 69 80 74 50 58 39 81 49 76 93 96% 103 106 80 
39 26 F DCLD B Y Y 3.6 3.6 3.5 5.4 2.4 3.1 7.2 56 78 53 64 75 49 64 45 100 78 56 75 97% 99 104 70 
40 56 M TB R N Y 3.5 3.3 3 5.2 2.3 2.7 7.7 47 72 64 82 71 50 66 46 95 64 87 104 95% 98 112 86 
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1 45 M N N 3.1 3.6 3.1 5.4 2.3 2.9 7.3 45 54 67 76 80 67 97 78 90 81 86 92 97% 90 104 78 
2 53 M N N 3.4 3.7 2.8 4.9 2.5 3 7.5 84 95 65 76 60 51 58 44 98 86 111 120 98% 95 120 86 
3 43 M N N 3.1 3.1 3.4 5.5 2.9 3.1 7 66 80 62 76 72 60 70 58 86 74 80 92 98% 98 100 70 
4 47 M N N 3.3 3.2 3.3 5.4 2.4 2.8 7.5 56 65 51 62 78 66 67 55 102 91 55 63 97% 97 110 74 
5 32 F N N 3.6 3.3 2.6 5 2.6 2.9 7.1 70 82 42 50 75 60 58 49 78 69 72 64 97% 98 110 80 
6 47 M N N 3.2 3.6 3 5.1 2.2 2.6 7.2 35 41 55 66 63 56 47 37 80 69 66 75 98% 96 110 80 
7 39 M N N 3.1 3.4 3.3 5.3 2.2 3.3 7.7 46 55 64 72 60 45 57 42 85 72 42 36 98% 100 116 80 
8 57 M N N 3.4 3.5 3 5.2 2.5 3.1 7.2 53 65 50 60 70 54 44 34 96 80 50 60 98% 92 110 78 
9 59 M N N 3.3 3.5 3.4 5.3 2.6 3 7.3 55 68 66 79 78 60 78 61 76 66 70 81 99% 93 120 80 
10 65 M N N 3.1 3 3.1 5.1 2.7 3 7.2 59 68 60 71 72 60 74 59 70 61 75 88 100% 93 120 82 
11 45 M N N 3.5 3.6 2.7 5 2.3 2.8 7.8 55 68 66 80 70 55 70 58 73 65 73 85 99% 96 110 80 
12 37 M N N 3.7 3.6 3 5.3 2.2 2.6 7.2 54 65 69 78 66 50 65 50 68 58 63 75 98% 93 120 76 
13 56 M N N 3.5 3.7 3.9 5.3 2.3 2.7 7.6 54 65 61 73 66 50 51 41 66 58 72 86 97% 97 110 86 
14 67 M N N 3.6 3.6 3.1 5.2 2.4 3 7.6 54 61 63 71 69 56 62 51 86 73 82 93 98% 90 124 80 
15 47 M N N 3.3 3.2 2.7 5 2.4 3.1 7.4 60 70 67 76 73 56 63 47 96 88 85 96 98% 90 120 80 
16 49 M N N 3.5 3.8 3 5.1 2.5 3.4 7.5 57 69 71 80 70 56 60 48 88 77 76 85 99% 90 126 78 
17 43 M N N 3.2 3 3 5.2 2.3 3.2 7.4 56 66 59 72 66 51 78 66 81 73 80 92 98% 92 120 80 
18 54 F N N 3.5 3.6 3.1 5 2.2 3.1 7.3 53 63 60 74 72 61 66 54 73 65 74 87 99% 90 118 78 
19 56 F N N 3.5 3.2 3.5 5.1 2.3 3 7.5 62 76 61 75 69 56 52 44 92 79 44 52 99% 91 118 80 
20 50 M N N 3.3 3.4 3.2 5.1 2.5 2.9 7.8 58 71 55 68 63 51 66 52 96 87 98 107 99% 89 120 80 
21 45 M N N 3.1 3.3 3.4 5.4 2.9 2.8 7.3 50 43 47 39 60 50 58 49 96 88 91 99 98% 92 110 80 
61 
22 46 F N N 3.4 3 3 5.1 2.2 3 7.6 50 59 46 53 50 41 45 39 87 76 60 70 99% 90 116 82 
23 40 M N N 3.1 3.7 3.1 5.2 2.3 2.9 7.5 55 64 52 62 76 59 65 55 98 86 68 76 99% 88 120 84 
24 38 M N N 3.3 3.5 3.8 5.1 2.8 3.1 7.8 59 67 53 68 66 48 69 48 69 57 45 54 99% 92 110 70 
25 30 M N N 3.5 3.2 3.4 5.3 2.7 3.2 7.6 47 66 67 80 40 28 68 46 88 75 67 78 98% 97 124 80 
26 42 F N N 3.2 3.4 3.1 5 2.2 2.9 7.6 49 65 59 70 72 50 60 45 83 70 73 84 97% 87 116 80 
27 26 M N N 3.4 3.4 3.5 5.3 2.2 2.5 7.4 45 54 60 74 69 45 51 34 86 74 45 56 99% 98 112 80 
28 43 M N N 3.5 3.5 3.5 5.3 2.4 3 7.5 65 79 47 64 72 54 78 59 68 56 47 60 98% 100 120 80 
29 38 F N N 3.3 3.3 3.2 5.1 2.8 3.1 7.2 45 57 62 77 69 44 49 32 66 56 68 75 99% 97 104 74 
30 60 M N N 3.2 3.6 3.6 5.1 2.4 2.8 7.4 56 69 60 75 65 40 67 50 64 50 71 83 98% 95 100 70 
31 45 M N N 3.3 3.5 3.7 4.9 2.7 2.6 7.6 46 54 65 79 80 58 44 30 63 52 63 75 97% 97 102 74 
32 75 M N N 3.5 3.5 3.6 5.3 2.7 3.2 7.3 34 40 39 55 78 57 48 34 96 84 84 93 98% 99 104 86 
33 56 M N N 3.1 3.5 3.8 5.2 2.3 3.2 7.7 56 67 48 66 73 55 43 25 91 75 76 85 98% 92 110 80 
34 38 M N N 3.3 3.2 3.4 5.4 2.4 2.9 7.3 59 68 61 72 72 52 57 40 68 52 63 75 98% 91 130 76 
35 40 M N N 3.1 3.2 3.6 5.2 2.4 3 7.5 66 86 71 83 65 47 54 34 85 70 79 90 99% 89 126 70 
36 37 M N N 3.5 3.4 3.1 5.5 2.6 3.1 7.5 55 69 59 74 68 47 65 49 90 75 48 57 99% 92 120 70 
37 42 M N N 3.1 3.6 3.5 5.1 2.4 3 7.4 54 61 69 84 75 57 70 52 65 51 45 55 96% 92 120 80 
38 50 M N N 3.2 3.6 3.6 5.1 2.3 3.3 7.4 50 63 52 67 72 50 73 55 75 55 78 90 97% 95 110 80 
39 26 F N N 3.5 3.6 3.2 5.4 2.4 3.2 7.4 56 68 57 74 62 45 75 58 72 60 83 94 96% 90 104 74 
40 56 M N N 3.4 3.3 3.1 5.3 2.4 2.9 7.7 53 66 45 62 60 41 53 37 69 52 91 102 99% 94 112 88 
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